
Citius Pharmaceuticals shares jumped 22.12% after hours following the commercial launch of its LYMPHIR therapy and a fiscal 2025 business update. Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumpe...
Citius Pharmaceuticals shares jumped 22.12% after hours following the commercial launch of its LYMPHIR therapy and a fiscal 2025 business update. Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumpe...